Abstract
In the last decade, Progress of acute myeloid leukemia (AML) induction therapy included: ① the increased treatment intensity; ② the inclusion of new durg; ③ the decreased early treatment related mortality. The perspective of AML induction therapy in the future included: ①the application of targeted drug; ② individualized stratification; ③ optimization and refinement of support and anti-infection therapy. The article focuses on progress and perspective of acute myeloid leukemia induction therapy. Key words: Leukemia, myeloid, acute; Remission induction; Molecular targeted therapy; Antineoplastic combined chemotherapy protocols; Prognosis; Age factors
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
